Featured Articles

1. Borrowed Brilliance: Is Pharma Becoming Overly Reliant On Acquisitions? 4/15/2025

   Denise Bronner, Ph.D., makes the case for and against acquisitions for rejuvenating Big Pharma pipelines. She explains why outsourcing innovation can be as risky, and costly, as internal discovery.

2. Securing Capital At The Right Moment: How Much Should Startups Ask For? 4/11/2025

   When funding is tight, life sciences startups must be even more strategic with requested amounts, timing, and funding sources, explains Michael Brooder.

3. How HHS Budget Cuts And Vaccine Hesitancy Threaten Clinical Trial Operations — And What Leaders Can Do 4/10/2025

   Prof. Stacey B. Lee, Ph.D., examines how the recent Department of Health and Human Services (HHS) staffing cuts and vaccine hesitancy combine to make clinical research much more challenging.

4. Understanding Re-Narcotization Is Key To Battling Opioids Like Fentanyl 4/9/2025

   Current short-acting opioid rescue agents were not designed to counteract oral fentanyl overdoses, and the mismatch can be dangerous, explains Elysium Therapeutics' Tom Jenkins, Ph.D. 

5. Amgen's Ian Thompson On Leadership And A Global Mindset 4/8/2025

   Ian Thompson, SVP and general manager of U.S. business operations at Amgen, shares his leadership philosophy, what he's learned from working in global markets, and key pipeline highlights.

6. How AI Redefines The Functional Service Provider Opportunity In Medical Affairs 4/7/2025

   Medical affairs can no longer afford to operate within legacy structures. Enter AI-enabled functional service provider (FSP) models that offer operational relief.

7. Biopharma Should Focus On Product Iteration Over Product Launches 4/4/2025

   Building iteration into the product commercialization process can help life sciences companies avoid many of the missteps that slow down adoption and stall growth, explains Jessica Meng.

8. Breaking Barriers: From Gendered Perceptions To Inclusive Leadership 4/2/2025

   Leadership in pharma means questioning assumptions, amplifying diverse voices, and creating environments where authenticity and empathy are recognized as strengths, explains Laryssa Wozniak.

9. Risk Management Planning: Be Prepared When Disaster Strikes 4/1/2025

   Few life sciences companies are ready for a disaster, particularly a cyber one. Key factors include an integrated approach to cyber preparedness and risk planning, a dedicated team, and more.

10. Companies To Watch: Imunon 3/31/2025

    Imunon aims to shake up the standard of care in the frontline treatment of advanced ovarian cancer.